FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311587798> ?p ?o ?g. }

• W4311587798 endingPage "419" @default.
• W4311587798 startingPage "419" @default.
• W4311587798 abstract "Importance Small cell lung cancer (SCLC) is an aggressive disease that is characterized by rapid growth and the early development of metastases. Patients typically respond to initial chemotherapy but quickly experience relapse, resulting in a poor long-term outcome. Therapeutic innovations that substantially improve survival have historically been limited, and reliable, predictive biomarkers are lacking. Observations This review examines the biologic characteristics of SCLC, the current treatment landscape, and ongoing efforts to identify novel therapeutic targets. Ongoing research has advanced the understanding of molecular categories and the immunologic microenvironment of SCLC, which in turn has helped improve disease classification and staging. Recently, immunotherapy-based regimens have become available for the management of SCLC, with 2 programmed cell death 1 ligand 1 inhibitors approved in combination with chemotherapy for first-line treatment of extensive-stage disease. For second-line treatment, a novel alkylating agent, lurbinectedin, which inhibits oncogenic transcription, has been approved for use in patients with metastatic SCLC. Furthermore, a wide variety of therapies and innovative combination regimens are being continuously evaluated. Potential therapeutic strategies, including aurora kinase A inhibitors, polyadenosine diphosphate-ribose polymerase inhibitors, ataxia telangiectasia and Rad3-related inhibitors, cyclin-dependent kinase 7 inhibitors, delta-like protein 3 agents, antiganglioside agents, CD47 inhibitors, and lysine-specific histone demethylase 1a inhibitors, are also being examined. Conclusions and Relevance Therapeutic optimization of SCLC remains a challenge, but recent trial results and drug approvals are encouraging. Advances in research have revealed critical information regarding biologic characteristics of the disease, which may lead to the identification of vulnerabilities and the development of new therapies. Further research focused on identifying biomarkers and evaluating innovative therapies will be paramount to improving treatment outcomes for patients with SCLC." @default.
• W4311587798 created "2022-12-27" @default.
• W4311587798 creator A5051036544 @default.
• W4311587798 creator A5052765751 @default.
• W4311587798 date "2023-03-01" @default.
• W4311587798 modified "2023-10-18" @default.
• W4311587798 title "Emerging Strategies for the Treatment of Small Cell Lung Cancer" @default.
• W4311587798 cites W1884032213 @default.
• W4311587798 cites W1903523058 @default.
• W4311587798 cites W1932169383 @default.
• W4311587798 cites W1971264126 @default.
• W4311587798 cites W1976228473 @default.
• W4311587798 cites W2023171799 @default.
• W4311587798 cites W2064462031 @default.
• W4311587798 cites W2065188377 @default.
• W4311587798 cites W2067056331 @default.
• W4311587798 cites W2070965927 @default.
• W4311587798 cites W2083904374 @default.
• W4311587798 cites W2101156795 @default.
• W4311587798 cites W2108927999 @default.
• W4311587798 cites W2132556766 @default.
• W4311587798 cites W2138683149 @default.
• W4311587798 cites W2150878803 @default.
• W4311587798 cites W2166392962 @default.
• W4311587798 cites W2185382808 @default.
• W4311587798 cites W2323020638 @default.
• W4311587798 cites W2480201404 @default.
• W4311587798 cites W2586697182 @default.
• W4311587798 cites W2598659203 @default.
• W4311587798 cites W2599941031 @default.
• W4311587798 cites W2642802273 @default.
• W4311587798 cites W2699278758 @default.
• W4311587798 cites W2745304695 @default.
• W4311587798 cites W2804287047 @default.
• W4311587798 cites W2804661897 @default.
• W4311587798 cites W2805476746 @default.
• W4311587798 cites W2808238124 @default.
• W4311587798 cites W2883600175 @default.
• W4311587798 cites W2890799019 @default.
• W4311587798 cites W2893960509 @default.
• W4311587798 cites W2905117225 @default.
• W4311587798 cites W2913103186 @default.
• W4311587798 cites W2928432651 @default.
• W4311587798 cites W2944244934 @default.
• W4311587798 cites W2969185256 @default.
• W4311587798 cites W2973098277 @default.
• W4311587798 cites W2977392388 @default.
• W4311587798 cites W2979144926 @default.
• W4311587798 cites W2980593108 @default.
• W4311587798 cites W2981636558 @default.
• W4311587798 cites W2995889981 @default.
• W4311587798 cites W2998740180 @default.
• W4311587798 cites W3013383466 @default.
• W4311587798 cites W3029500016 @default.
• W4311587798 cites W3029678115 @default.
• W4311587798 cites W3030792017 @default.
• W4311587798 cites W3031146226 @default.
• W4311587798 cites W3031682330 @default.
• W4311587798 cites W3032096744 @default.
• W4311587798 cites W3081953801 @default.
• W4311587798 cites W3083344515 @default.
• W4311587798 cites W3085646757 @default.
• W4311587798 cites W3092349179 @default.
• W4311587798 cites W3093252548 @default.
• W4311587798 cites W3104932451 @default.
• W4311587798 cites W3124749091 @default.
• W4311587798 cites W3132559292 @default.
• W4311587798 cites W3133896744 @default.
• W4311587798 cites W3138418752 @default.
• W4311587798 cites W3151827122 @default.
• W4311587798 cites W3154101159 @default.
• W4311587798 cites W3155388144 @default.
• W4311587798 cites W3160964078 @default.
• W4311587798 cites W3166170782 @default.
• W4311587798 cites W3212440904 @default.
• W4311587798 cites W4220970211 @default.
• W4311587798 cites W4280533169 @default.
• W4311587798 cites W4306247391 @default.
• W4311587798 doi "https://doi.org/10.1001/jamaoncol.2022.5631" @default.
• W4311587798 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36520421" @default.
• W4311587798 hasPublicationYear "2023" @default.
• W4311587798 type Work @default.
• W4311587798 citedByCount "10" @default.
• W4311587798 countsByYear W43115877982023 @default.
• W4311587798 crossrefType "journal-article" @default.
• W4311587798 hasAuthorship W4311587798A5051036544 @default.
• W4311587798 hasAuthorship W4311587798A5052765751 @default.
• W4311587798 hasConcept C121608353 @default.
• W4311587798 hasConcept C126322002 @default.
• W4311587798 hasConcept C143998085 @default.
• W4311587798 hasConcept C2776256026 @default.
• W4311587798 hasConcept C2777701055 @default.
• W4311587798 hasConcept C2779134260 @default.
• W4311587798 hasConcept C502942594 @default.
• W4311587798 hasConcept C71924100 @default.
• W4311587798 hasConceptScore W4311587798C121608353 @default.
• W4311587798 hasConceptScore W4311587798C126322002 @default.
• W4311587798 hasConceptScore W4311587798C143998085 @default.

• next